Hemoglobin Measured by "Orsense NBM-200MP" Device and Laboratory Measurement
Completed
- Conditions
- Emergency
- Registration Number
- NCT01321593
- Lead Sponsor
- Hopital Foch
- Brief Summary
The purpose of this study is to compare the hemoglobin results obtained with the "Orsense NBM-200MP" device and the Clinical Laboratory.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- emergency unit patients requiring an hemoglobin determination
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin measurement using the "Orsense NBM-200MP" device 4 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of non-invasive hemoglobin monitoring in emergency settings?
How does the Orsense NBM-200MP compare to standard-of-care hemoglobin measurement in clinical accuracy?
What biomarkers correlate with hemoglobin variability in acute patient populations?
What adverse events are associated with non-invasive hemoglobin monitoring devices in emergency medicine?
How do non-invasive hemoglobin monitoring technologies compare to other point-of-care diagnostic tools in emergency care?
Trial Locations
- Locations (1)
Hôpital Foch
🇫🇷Suresnes, France
Hôpital Foch🇫🇷Suresnes, France